CHROMOPHOBE RENAL CELL CARCINOMA
Clinical trials for CHROMOPHOBE RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CHROMOPHOBE RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CHROMOPHOBE RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: Triple-Drug attack shows promise
Disease control Recruiting nowThis phase II trial is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can shrink or slow the growth of rare genitourinary cancers that have spread. About 314 adults with these uncommon tumors will receive the drugs. The goal is to see if the …
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC
-
New smart drug targets tough cancers in early human test
Disease control Recruiting nowThis early-stage trial tests a new drug called NN3201 in people with advanced cancers that have a specific marker called c-Kit. The drug is designed to deliver a chemotherapy agent directly to cancer cells, potentially killing them while sparing healthy tissue. The study will enr…
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Novelty Nobility, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Scientists track Cancer's diet in real time during surgery
Knowledge-focused Recruiting nowThis study looks at how kidney and bladder cancers use nutrients like sugar and fat to grow. Participants receive a harmless nutrient tracer during surgery or biopsy, and researchers collect blood and tissue samples to analyze cancer metabolism. The study does not change standard…
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC